[1] Torre L A, Bray F, Siegel R L, et al. Global cancer statistics, 2012[J]. CA Cancer J Clin, 2015, 65(2):87-108. [2] Pajares J A, Perea J. Multiple primary colorectal cancer:individual orfamilial predisposition?[J]. World J Gastrointest Oncol, 2015, 7(12):434-444. [3] Lam A K, Chan S S, Leung M. Synchronous colorectal cancer:clinical, pathological and molecular implications[J]. World J Gastroenterol, 2014, 20(22):6815-6820. [4] Lee J W, Kim J W, Kim N K. Clinical characteristics of colorectal cancer patients with a second primary cancer[J]. Ann Coloproctol, 2014, 30(1):18-22. [5] van Leersum N J, Aalbers A G, Snijders H S, et al. Synchronous colorectal carcinoma:a risk factor in colorectal cancer surgery[J]. Dis Colon Rectum, 2014, 57(4):460-466. [6] Mulder S A, Kranse R, Damhuis R A, et al. Prevalence and prognosis of synchronous colorectal cancer:a Dutch population-based study[J]. Cancer Epidemiol, 2011, 35(5):442-447. [7] Amin M B, Edge S, Greene F, et al. AJCC cancer staging manual[M]. 7th ed. Germany:Springer, 2010:1726-1727. [8] 牛丽云, 张峻岭, 刘天野, 等. 结直肠同时性多原发癌的临床病理特征和预后分析[J]. 中华胃肠外科杂志, 2018, 21(1):41-45. [9] Lee B C, Yu C S, Kim J, et al. Clinicopathological features and surgical options for synchronous colorectal cancer[J]. Medicine (Baltimore), 2017, 96(9):e6224. [10] Lam A K, Carmichael R, Gertraud Buettner P, et al. Clinicopathological significance of synchronous carcinoma in colorectal cancer[J]. Am J Surg, 2011, 202(1):39-44. [11] Nikoloudis N, Saliangas K, Economou A, et al. Synchronous colorectal cancer[J]. Tech Coloproctol, 2004, 8 Suppl 1:s177-179. [12] Mohammadi M, Kristensen M H, Nielsen H J, et al. Qualities of sessile serrated adenoma/polyp/lesion and its borderline variant in the context of synchronous colorectal carcinoma[J]. J Clin Pathol, 2012, 65(10):924-927. [13] Abe S, Terai T, Sakamoto N, et al. Clinicopathological features of nonpolypoid colorectal tumors as viewed from the patients' background[J]. J Gastroenterol, 2006, 41(4):325-331. [14] Kato T, Alonso S, Muto Y, et al. Clinical characteristics of synchronous colorectal cancers in Japan[J]. World J Surg Oncol, 2016, 14(1):272-279. [15] Malapelle U, De Stefano A, Carlomagno C, et al. Next-generation sequencing in the genomic profiling of synchronous colonic carcinomas:comment on Li et al (2015)[J]. J Clin Pathol, 2015, 68(11):946-947. [16] Easson A M, Cotterchio M, Crosby J A, et al. A population-based study of the extent of surgical resection of potentially curable colon cancer[J]. Ann Surg Oncol, 2002, 9(4):380-387. [17] Holubar S D, Wolff B G, Poola V P, et al. Multiple synchronous colonic anastomoses:are they safe?[J]. Colorectal Dis, 2010, 12(2):135-140. [18] Huang C S, Yang S H, Lin C C, et al. Synchronous and metachronous colorectal cancers:distinct disease entities or different disease courses?[J]. Hepatogastroenterology, 2015, 62(140):838-842. [19] Nosho K, Kure S, Irahara N, et al. A prospective cohort study shows unique epigenetic, genetic, and prognostic features of synchronous colorectal cancers[J]. Gastroenterology, 2009, 137(5):1609-1620.e1601-1603. [20] Bae J M, Cho N Y, Kim T Y, et al. Clinicopathologic and molecular characteristics of synchronous colorectal cancers:heterogeneity of clinical outcome depending on microsatellite instability status of individual tumors[J]. Dis Colon Rectum, 2012, 55(2):181-190. [21] 蒋松松, 陈刚,郑黎明,等.同时性多原发结肠癌误诊三例临床分析[J].临床误诊误治,2016,29(1):21-24. |